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The mammalian maternal fetal relationship appears to contradict basic principles of 
transplantation immunology in that the implanted fetus represents a histoincompatible 
allograi~  exposed  to,  but  well  tolerated  by,  a  potentially  harmful  maternal-immune 
system (1). Available information suggests that exemption of the fetus from premature- 
immune  attack  depends  in  part  on  the  cumulative  action of specific  and  nonspecific 
immunoregulatory factors (2-6). Recent studies (7-9) indicate that one of  the contributing 
regulatory factors may be alpha-fetoprotein (AFP), ~ a  major alpha-globulin component 
of fetal and newborn sera. The implication that AFP may have important immunoregu- 
latory function in vivo is based on its demonstrated ability to selectively suppress 
human and murine immune responses in vitro (7-14),  and is further supported by the 
frequent association of elevated levels of AFP with the immunological hyporeactivity 
present in some normal (15, 16) and pathological (17-22) conditions. 
Evidence from both the human and murine systems indicate that the effects of AFP 
in vitro are restricted to certain functions of thymus-derived (T) lymphocytes, with no 
apparent direct effects on B cells (10, 23).  2 For example, in the mouse, T-cell-dependent 
antibody  synthesis,  T-cell  mitegenic  responsiveness,  and  T-cell-mediated  allogeneic 
reactivity are suppressed by AFP (8, 9), whereas polyclonal B-cell activation and T-cell- 
independent antibody responses are not affected (10). Recently it has been reported (24) 
that murine AFP does not inhibit the in vitro induction of antigen-specific helper T cells 
directly, but instead,  induces the formation of suppressor T cells which can effectively 
interfere with the co-operative interaction between B and T cells,  yet have no influence 
on B-cell responses to T-independent antigens. Similarly, in the human system, AFP, at 
concentrations which significantly inhibit  alloantigen-induced and T-mitogen-induced 
lymphocyte transformation, fails to affect the mitogenic responses to the human B-cell 
mitogen Protein A of Staphylococcus aureus. 2 
Controversy  concerning  the  immunosuppressive  activity  of AFP  on  T-dependent 
responses has surfaced after a number of reports (25-29) indicating that AFP exhibits 
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only  weak  or  variable  suppressive  activity on in  vitro T-cell responses.  Furthermore, 
Parmely  and  Thompson  (30)  have  suggested  that  the  immunosuppressive  activity 
associated with AFP is not due to AFP per se but to contaminants  in the preparation. 
Similarly,  it  has  also  been  claimed  (31)  that  AFP  must  first  bind  estrogen  before 
obtaining the capacity to elicit suppressive activity. 
We have undertaken a systematic study of the possible regulatory influence 
of AFP on the proliferative and effector phases of the T-cell-mediated-immune 
reaction utilizing the in vitro mixed leukocyte culture (MLC) and cell-mediated 
lympholysis (CML) assays. In this first report, we present evidence that highly 
purified fetal-derived AFP can exert differential effects on both the primary 
and  secondary  MLC  responses  of purified  T-cell  populations  ranging  from 
strong inhibition  to  occasional enhancement. Data shown here indicate that 
proliferative  responses  of  T  lymphocytes  towards  major  histocompatibility 
complex  (MHC)  I  region  determinants  are  markedly  suppressed  by  AFP, 
whereas responses against MHC serologically-defined (SD) region alloantigens 
are generally unaffected. In addition,  AFP is shown to exhibit a  differential 
effect on  MLC  activity induced by non-MHC  alloantigens,  with suppression 
occurring only in those antigenic systems whose recognition is dependent on a 
concomitant recognition of I  region gene products.  The regulatory effects of 
AFP on T-cell proliferation noted in this study, therefore, appear to be restricted 
by the genetic relationship between responding and stimulating cells and/or a 
differential activity on subclasses of T lymphocytes. 
Materials and Methods 
Mice.  Inbred strains of mice used in this study and maintained in our laboratory are A.CA, 
A.TH, A.TL, B10.A, B10.AKM,  B10.BR,  B10.D2/n,  B10.G,  B10.HTT,  B10.M, B10.S, B10.S(TR), 
B10.T(6R), CBA/H, CBA-H-2  ka, CBA/J, C3H/HeJ, C3H/Tif, C57BL/6Bom, DBA/2, and the hybrid 
(A.SW  x  CBA/H)FI.  The congenic resistant  partner  strains  of C57BL/10Sn,  were established 
from breeding pairs provided by Dr. F. H. Bach (Immunobiology Research Center, University of 
Wisconsin, Madison, Wis.). Strains A.TH and A.TL were provided by Dr. P. Petersson (Medical 
Chemistry,  Biomedical Center, Uppsala, Sweden) and the mutant strain,  CBA-H-2  ka, by Dr.  L. 
C.  Andersson  (4th  Department  of Pathology,  University of Helsinki,  Finland).  Both male and 
female mice were utilized and ranged in age from 4 to 24 wk. 
Amniotic fluid was obtained from pregnant female outbred mice which were purchased from 
Antieimex AB (Stockholm, Sweden). 
Culture Medium.  The serum-free medium as described by Click et al. (32) and Heber-Katz et 
al.  (33) was supplemented with 0.5%  normal mouse serum according to the protocol of Peck and 
Click  (34). The  mouse  serum  was  homologous with  the  responding  strain  and  pooled from  a 
minimum of three animals. 
AFP.  AFP was purified from amniotic fluid by affinity chromatography and preparative gel 
electrophoresis according to procedures described elsewhere (8). 
MLC Combinations.  Primary  MLCs were performed in microtiter plates  (no.  M 24A, Cooke 
Microtiter System,  Novakemi AB, Farsta,  Sweden) or in tissue culture flasks  (no.  3013,  Falcon 
Plastics,  Div.  of Bioquest,  Oxnard,  Calif.)  according  to  procedures  described  elsewhere  (35). 
Flask  cultures  were  employed  to  generate  alloantigen-activated  T-cell  blasts  used  in  the 
secondary MLCs.  Each flask contained 20-25  ×  108 responding T lymphocytes cultured together 
with an equal number of X-irradiated (2,000 rads) stimulating cells in 12 ml of medium. 
All secondary  MLCs were performed in microtiter plate cultures  as previously described by 
Peck et al.  (36).  Cultures consisted of 0.05  ×  106 or 0.075  ×  106 responding T-cell blasts cultured 
together with 0.5  ×  10  ~ X-irradiated stimulating spleen cells. 
At appropriate  times  of primary  or secondary  culture,  as  indicated  in  the text  and  figure 
legends, 0.8 ~Ci tritiated-thymidine ([3H]TdR)  (Amersham, London, England) in a vol of 0.02 ml AMMON  B.  PECK,  ROBERT  A.  MURGITA,  AND  HANS  WIGZELL  669 
was added to each well for 4  h.  Cells were filtered through glass-fiber filters with a  multiple- 
sample harvester (Skatron, Flow Laboratories, Stockholm, Sweden) and total [~HJTdR  incorpora- 
tion was determined by liquid scintillation procedures.  Data are expressed in counts per minute 
of the  mean  of either  duplicate  or  triplicate  cultures.  Standard  deviations of the  means  are 
generally included. 
Preparation of Splenic  T  Lymphocytes.  In  the  majority  of cases,  the  responding  cells  in 
primary MLC were prepared by passage of whole spleen cell suspensions whose contaminating 
erythrocytes had been lysed in a  0.84% NH4C1 treatment through Ig-anti-Ig glass bead columns, 
according to the protocol of Wigzell et al.  (37).  This procedure removes Ig-bearing B cells. After 
passage  through the columns,  the  nonadherent cells  are  washed twice  in phosphate-buffered 
saline (PBS) and resuspended to a density of 100  ×  l0  s cells per ml. The resulting cell population 
can be shown to be >98% theta antigen-bearing T cells and <0.5% Ig-bearing B cells. 
Separation  of MLC-Reactive T-Blast  Cells from  Primary  Cultures.  The  MLC-reactive  T 
lymphocytes  were  separated  as  T-blast  cells  from  the  nonresponsive  populations  using  1 g 
velocity sedimentation procedures  as described by Miller and Phillips (38)  and Andersson and 
H~yry  (39).  Primary MLC cells were collected from the culture flasks after maximum [~H]TdR 
incorporation,  resuspended  in  PBS  supplemented  with  4%  fetal  bovine  serum  (FBS),  then 
layered over a linear 15-30% FBS gradient. The cells were permitted to fall through the gradient 
for 2-4 h.  Fractions of 12 ml each were collected and microscopically examined for numbers of 
blast and nonblast cells. Only those fractions containing >95% blast cells were kept. After two to 
four washes with PBS, the resulting pooled T-lymphocyte blast cell suspension was dispensed to 
microtiter plate wells and restimulated with appropriate stimulating cell populations. 
LY Antigen Phenotype Determinations.  Complement-dependent cytotoxic reactions were car- 
ried  out  according  to  the  protocol  of Shiku  et  al.  (40).  Ly  antisera  used  in  this  study  were 
generously provided by Dr.  K.  I.  Welsh (McIndoe Research Unit,  Queen Victoria Hospital,  E. 
Grinstead, England). 
Results 
In the mouse, lymphocyte proliferation as measured by MLC can be induced 
by genetic differences associated with the MHC (reviewed in references 41 and 
42) or with loci segregating independently of the MHC  (43-46) (referred to as 
non-MHC  loci  in  the  present  report).  The  various  regions  and  subregions 
comprising the MHC contain genes which code for at least two distinct classes 
of membrane-bound MLC-activating products. The K and D regions encode for 
the classical SD determinants, whereas the I  region genes encode for the Ia 
antigens. Both the SD and Ia molecules, besides initiating lymphocyte  prolifer- 
ation,  appear  to  function as  target antigens for cytotoxic T  lymphocytes in 
CML  (47, 48). Two MLC-stimulating, non-MHC antigenic systems of interest 
for the present investigation are the Mls locus (43, 44) and an as yet undefined 
system  which  became  readily  distinguishable  from  the  Mls  locus  through 
lymphocyte-typing  analysis (46). The non-MHC alloantigens apparently cannot 
function as target antigens for cytotoxic T lymphocytes. These four classes of 
determinants, together with  the  presently known requirements involved in 
their recognition, are listed in Table I.  Note that Mls  locus products induce 
lymphocyte proliferation only if there is concommitant recognition of MHC I 
region gene products (46). In the results to follow,  the differential activity of 
AFP  on  responses  directed  towards  these  four  classes  of antigens  further 
delineates the different nature of each system. 
Effects of AFP on Primary and Secondary  MLC Responses against MHC- 
Associated Alloantigens.  The effects of AFP on primary and secondary MLC 
reactivity induced by  MHC-associated genetic differences were investigated 
using congenic resistant partner strains of both the C57BL/10 and A/Sn mouse 670  SELECTIVE  IMMUNOREGULATORY  EFFECTS  OF ALPHA-FETOPROTEIN 
TABLE  I 
A Listing of MLC-Stimulating AUoantigenic Systems 
MLC-Stimulating al-  Required recognition  in MLC  Antigen  target  in 
loantigen*  MHC-Ia  MHC-SD  Mls locus  Non-MHC  CML 
MHC-Ia  +  -  -  -  + 
MHC.SD  -  +  -  -  + 
Mls Locus  +  -/?  +  -  - 
Undefined non-MHC  -  -  -  +  - 
* Reviewed in Klein (41) and Peck et al. (46). 
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Fio. i.  Effects  of AFP on the primary MLC  responses of splenic lymphocytes against 
MHC-associated histocompatibility  alloantigens.  The kinetics  of  primary MLC  activation 
for  B10.BR spleen cells  and  purified  splenic  T lymphocytes responding against X-irradiated 
B10.HTT spleen cells  were carried out in the absence (e  e) or presence (O  ©) of 
AFP  (150 /~g/ml).  Syngeneic stimulated control cultures in the absence (m  B) and 
presence (y] -  [~)  of  AFP are also  shown. [3H]TdR (0.8  ~Ci) was added to  each culture  4 h 
before harvesting the cells  at the times indicated. 
groups.  First,  the  kinetics  of primary  MLC  activation  in  the  presence  and 
absence of AFP were examined for both B10.BR whole splenic leukocytes and 
purified splenic T  lymphocytes responding  against B10.HTT,  a  representative 
anti-MHC  reaction.  As  shown  in  Fig.  1,  strong  primary  MLC  reactions  are 
exhibited  by  both  responding  populations  in  the  absence  of  AFP.  In  the 
presence of AFP, however, a  suppressed [3H]TdR incorporation rate is observed 
for  both  splenic  leukocytes  and  purified  T  cells  throughout  the  time-course AMMON  B.  PECK,  ROBERT  A.  MURGITA,  AND  HANS  WIGZELL  671 
TABLE  II 
The Effects  of AFP on the In Vitro Stimulation of Splenic T Lymphocytes  against MHC 
Alloantigens 
Group  Responding T lympho-  Stimulating cells 
cytes* 
MHC Derivation$  [SH]TdR Incorporation  (cpm ± SD) 
K  I-A  I-B  I-C  S  G  D  NMS Control§  +  AFP§ 
A  BI0.D2/n  BI0.D2/n 
BI0.BR 
d  d  d  d  d  d  d  1,028 ±  34  3,150 ±  59 
k  k  k  k  k  k  k  41,466  ±  203  25,455 ±  605 
s  s  s  s  s  s  d  9,899 ±  1,365  12,813  ±  2,638 
k  k  k  k  k  k  k  38,268 ±  3,322  27,776 ±  2,047 
B10.S(7R)  B10.S(7R) 
B10.BR 
(A.SW x  CBA/H)F1  (A.SW x  CBA/H)F~  s/k  s/k  s/k  s/k  s/k  s/k  s/k  2,129 ±  350  4,422 ±  1,159 
A.CA  f  f  f  f  f  f  f  22,426  ±  149  6,660 ±  1,205 
B10.S(7R) anti-B10.BR  B10.S(7R)  s  s  s  s  s  s  d  4,608 ±  734  1,670  ±  611 
B10.BR  k  k  k  k  k  k  k  112,390 ±  177  70,053  ±  9,002 
B10.A anti-B10.S(7R)  B10.A  k  k  k  d  d  d  d  18,858  ±  1,312  13,929  ±  1,812 
B1O.S (7R)  s  s  s  s  s  s  d  53,300  ±  2,339  25,617  ±  1,208 
B10.S  s  s  s  s  s  s  s  99,005 ±  4,242  44,625 ±  2,131 
B10.HTT  s  s  s  k  k  k  d  71,027  ±  878  34,430 ±  473 
* T lymphocytes purified by passage through Ig-anti.Ig columns.  Blast cells isolated on 1 g  velocity sedimentation gradients aRer peak 
primary MLC activation. 
$ Underlined letters designate MHC regions against whose gene products the responding T-cell populations are sensitized. 
§ AFP added at initiation of secondary MLC to a final concentration of 150 p,g/ml.  Control cultures received an equivalent concentration 
of normal mouse serum (NMS). 
studied. A similar suppression of primary MLC by AFP has been observed in 
several other MHC histoincompatible strain combinations. Three such combi- 
nations  are shown in group A of Table II and depict the variable degree of 
suppression  generally effected by  AFP,  ranging  from  marginal  (as  in  the 
reaction of B10.S(7R) responding against B10.BR) to strong (as in the reaction 
of (A.SW × CBA/H)F1 against A.CA). 
Recently, a procedure has been described (36) which permits the isolation of 
specific, alloantigen-reactive T-blast cells from primary MLC using 1 g velocity 
sedimentation gradients. Such purified T cells are specifically restimulated in 
secondary MLC  only by the  original priming or cross-reactive alloantigens. 
This protocol was employed here to  allow the investigation of the effects of 
AFP on secondary responses against MHC alloantigens. Results of experiments 
with purified T blasts are presented in group B of Table II for the reactions of 
B10.S(7R)  anti-B10.BR  and  B10.A  anti-B10.S(7R),  two  strain  combinations 
possessing both MHC SD and I  region differences. AFP, added at initiation of 
secondary stimulation to a final concentration of 150 ~g/ml, suppresses second- 
ary MLC  responses against  MHC  differences between 40  and 60%, approxi- 
mately to the same degree usually observed in primary anti-MHC reactions. 
Secondary stimulation by third party strains sharing MHC  SD  and I  region 
identity with  the  specific  priming  strain,  e.g.,  B10.S and  B10.HTT  in  the 
reaction of B10.A  anti-B10.S(7R),  are similarly suppressed.  Thus,  it appears 
that AFP can significantly suppress the MLC reactivity of T cells responding 
against MHC SD plus I  region incompatibilities. 
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TABLE III 
Differential  Effects  of AFP on the In Vitro Stimulation of T Lymphocytes Sensitized 
against Either MHC I or SD Region Alloantigens 
Primary and sec-  MHC Derivation* 
Responding T lymphocytes*  ondary MLC stimu- 
lating cells  K  I-A  I-B  I-C  S  G  D 
[3H]TdR Insorpora-  (cpm  ±  SD) + 
tion NMS Control§  AFP§ 
A.TL anti-B10.S(7R)  A.TL  s  k  k  k  k  k  d  11,840-625  7,903-453 
B10.S(7R)  s  s  s  s  s  s  d  56,332-875  28,087-302 
B10.S(7R)  B10.S(7R)  s  s  s  s  s  s  d  1,017-87  994-108 
B10.S  s  s  s  s  s  s  s  15,656-40  13,258-384 
CBA-H-2  ka  CBA-H-2  k~  ka  k  k  k  k  k  k  3,422-254  3,906-776 
CBA/H  k  k  k  k  k  k  k  41,440-546  37,156-213 
B10.AKM anti-B10.BR  B10.AKM  k  k  k  k  k  k  q  4,864-1,031  5,772-120 
B10.BR  k  k  k  k  k  k  k  24,784-1,719  23,365-708 
* Blast cells isolated on 1 g  velocity sedimentation gradients after peak primary MLC activation. 
Underlined letters designate MHC region(s) against whose gene products the responding T-cell population is sensitized in the 
primary MLC. 
§ AFP added  at  initiation of secondary  MLC  to a  final concentration  of 150  /~g/ml.  Control  cultures received an  equivalent 
concentration of normal mouse serum (NMS). 
Region  Determinants  of  the  MHC.  MHC  recombinant  strains  possessing 
limited  genetic  differences  permit  the  study  of the  effects of AFP  on  MLC 
reactions  induced  by  individual  region  or  subregions  of the  MHC.  Results 
presented  in  Table  III  show  the  effects  of  AFP  on  selected  primary  and 
secondary MLC reactions directed specifically against I  or SD region incompat- 
ibilities.  AFP clearly suppresses the reaction directed towards I  region differ- 
ences, as defined by the combination A.TL-B10.S(7R), but has little or no effect 
on the proliferative responses directed towards SD region histoincompatibilities, 
as.  defined  by  the  combinations  B10.S(7R)-B10.S,  CBA-H-2ka-CBA/H,  and 
B10.AKM-B10.BR. Although strains A.TL and B10.S(7R) differ genetically not 
only at the MHC I  region but also at both the MHC S  and G regions as well as 
in the background, the A.TL anti-B10.S(7R) blast cells can be shown in primed- 
lymphocyte typing analysis to be restimulated only by I  region-associated gene 
products (A. B. Peck, unpublished data). This rules out the involvement of these 
additional  non-/  region  genetic  differences  and  suggests  that  AFP-induced 
suppression  in  MHC  histoincompatible  strain  combinations  must  be due,  at 
least in part,  to suppression of cellular proliferation  against I  region alloanti- 
gens.  It  should  also  be  noted  that  the  addition  of AFP  to  such  secondary 
reactions of blast lymphocytes generally  (but not absolutely) results  in rapid 
suppression of the ongoing proliferation  (e.g.,  the  response of the  A.TL anti- 
B10.S(7R) blast cells against syngeneic A.TL cells). It appears,  therefore, that 
the  residual  reactivity  of the  activated  blast  cells  against  the I  region  gene 
products  is  also  sensitive  to  inhibition  by  AFP.  In  contrast,  primary  and 
secondary proliferative responses directed towards isolated SD region alloanti- 
gens,  as shown in Table III, are refractive to suppression by AFP. Two strain 
combinations,  B10.S(7R) anti-B10.S  and  B10.AKM anti-B10.BR,  which  differ 
genetically  at  MHC  D,  exhibit  specific responsiveness  in primed-lymphocyte 
typing analysis towards the MHC D region-associated alloantigens  defined by 
specificities  H-2.12  and  H-2.32,  respectively  (A.  B.  Peck,  unpublished  data). AMMON  B.  PECK,  ROBERT  A.  MURGITA,  AND  HANS  WIGZELL  673 
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Fro. 2.  Differential  effects  of  AFP on the secondary MLC activation  of  isolated,  alloanti- 
gen-activated  T lymphocytes sensitized  to  either  MHC  I or MHC  SD region determinants. 
A. The kinetics  of  secondary MLC  activation  for  B10.S(7R) anti-B10.HTT blast  cells  with 
spleen cells  from B10.HTT in the absence (Q  @) or presence (O  O) of  AFP. B. The 
kinetics  of  secondary  MLC activation  for  B10.G  anti-B10.T(SR)  blast  cells  with  X-irradiated 
B10.T(SR)  spleen cells in the absence (O  0)  or presence (C)  O)  of AFP.' 0.8  i~Ci 
[SH]TdR was added to each culture 4 h before harvesting the cells at the times indicated. 
Reactivity between strains CBA-H-2  ka and CBAJH is believed to result from a 
gain loss mutation associated with the MHC K  region. Thus, the lymphocyte 
proliferation observed is most probably induced by the parent mutation strain- 
defined SD specificity H-2.60 (see reference 41). 
This selective inhibitory action of AFP on anti-MHC I  region responses is 
again very clearly exemplified in Fig. 2. The two strain combinations examined 
here are B10.S(7R) responding against B10.HTT  or B10.G responding against 
B10.T(6R).  The  major  genetic  difference between  B10.S(7R) and  B10.HTT 
important for MLC activation is the presence of/region antigen Ia.7 expressed 
in strain  B10.HTT  (42, 46). On the other hand,  B10.G  and B10.T(6R)  share 
MHC region identity except at D, and the reaction of B10.G against B10.T(6R) 
appears to be directed against a  portion of the SD molecule defined by, but 
distinct from, SD specificity H-2.4 (ABP, unpublished data). Both the anti-Ia.7 
and  the  anti-SD  reactions exhibit  typical secondary-like profiles  with  peak 
[3H]TdR incorporation occurring between 24 and 48 h  of culture. Again, AFP 
can be seen to exert a highly selective activity: the restimulation of B10.S(7R) 
anti-B10.HTT blasts by Ia.7 is strongly suppressed, whereas the restimulation 
of B10.G anti-B10.T(6R)  blasts by the D region molecule(s) is unaffected. 674  SELECTIVE  IMMUNOREGULATORY EFFECTS OF  ALPHA-FETOPROTEIN 
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FIG. 3.  Effects  of AFP on the primary MLC  responses of splenic  lymphocytes against 
non-MHC-associated alloantigens.  The kinetics  of primary MLC  activation  for B10.BR 
spleen cells  and purified  splenic  T lymphocytes responding against X-irradiated  C3H/HeJ 
cells  were carried  out in the absence (•  •) or  presence (©  ©) of  AFP (150  ~g/ml). 
Syngeneic  stimulated cultures  in  the absence (I  i) and presence ([]  O) of  AFP are 
included. [3H]TdR (0.8  ftCi)  was added to each culture  4 h before  harvesting the cells  at 
the times indicated. 
Effects  of AFP on Primary  and  Secondary  MLC Responses  against Non- 
MHC-Associated Alloantigens.  To test the effects of AFP on the proliferative 
responses towards non-MHC alloantigens, the kinetics of primary MLC activa- 
tion  for  whole  splenic  leukocytes and  purified  splenic  T  lymphocytes from 
B10.BR  mice stimulated with spleen cells from C3H/HeJ  mice were studied. 
Both B10.BR and C3H/HeJ carry the MHC k  haplotype but differ genetically 
at numerous non-MHC loci, including the MLC-stimulating Mls locus (43, 44). 
Results,  shown in Fig.  3,  indicate that AFP effectively suppresses  this anti- 
non-MHC response elicited by both responding cell populations. 
Examples of secondary MLC responses against non-MHC alloantigens in the 
presence and absence of AFP are shown in group A, Table IV. Results with the 
three reactions of B10.BR anti-C3H/Tif, B10.M anti-A.CA, and B10.S(7R) anti- 
A.TH indicate that AFP can also exert strong suppressive effects on secondary 
MLC activation induced by non-MHC genetic differences. The major stimulat- 
ing determinant(s) in each of these three reactions are considered to be the Mls 
locus product. 
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TABLE  IV 
Differential Effects of  AFP on the In Vitro Activation of Splenic T Lymphocytes by Non- 
MHC Alloantigens 
Group  Responding T lympho-  Stimulating  Genetic differencos$ 
cytes*  cells 
[SH]TdR Incorporation  (cpm ± SD) 
NMS Control§  +  AFP§ 
A  B10.BR anti-C3Hfrif  B10.BR  None  9,169  ±  631  10,357  ±  893 
C3Hfrif  Non-MHC, M/s locus  127,767  ±  3,258  78,330  ±  6,551 
C57BL/6  Non-MHC crese-reactivity  80,435  ±  1,368  40,830  ±  2,115 
B10.M anti-A.CA  B10.M  None  21,380  ±  160  19,214  ±  1,378 
A.CA  Mls locus  46,874  ±  3,369  16,900  ±  2,757 
B10.S(7R)  anti-A.TH  B10.S(7R)  None  16,997  ±  765  20,163  ±  274 
A.TH  Mls locus  25,046  ±  753  19,896  ±  675 
B  B10.D2/n  B10.D2/n  None  1,382  ±  25  2,817  ±  134 
DBA/2  Non-MHC, Mls locus  2,457  ±  334  7,446  ±  1,190 
CBA/J  CBA/J  None  1,012  ±  100  676 ±  149 
DBA/2  MHC, Non-MHC, Mls locus  59,855  ±  2,231  93,385  ±  4,181 
B10.BR anti-CBA/J  B10.BR  None  976 ±  210  1,887  ±  188 
CBA/J  Non-MHC, M/s locus  34,891  ±  3,184  34,233  ±  1,161 
DBA/2  Non-MHC cress-reactivity  21,299  ±  4,840  19,645  ±  503 
* T lymphocytes purified by passage through Igoanti-Ig columns. Blast cells isolated on 1 g  velocity sedimentation gradients aRer 
peak primary MLC activation. 
Genetic difference considered responsible for activation of T cells in MLC. 
§ AFP added  at  initiation  of primary or secondary  MLC to  a  final concentration  of 150  pg/ml.  Control  cultures  received an 
equivalent concentration  of normal mouse serum (NMS). 
ences have been found whose proliferative responses were either not signifi- 
cantly inhibited by AFP or were actually enhanced. Such combinations, as a 
rule,  contained  either  DBA/2  or  CBA/J  as  the  stimulating  cell  type.  One 
example, shown in Fig. 4, is the kinetic responses of whole splenic leukocytes 
and  purified  splenic  T  lymphocytes from  B10.G  responding  against  DBA/2 
cells, a strain combination possessing both MHC and non-MHC genetic differ- 
ences. In addition, the MHC activations of other strain combinations, including 
B10.D2/n  anti-DBA/2,  CBA/J  anti-DBA/2,  and  B10.BR  anti-CBA/J,  are also 
unaffected or slightly enhanced (group B, Table IV). It appears, therefore, that 
AFP suppresses proliferative responses against M/s locus incompatibility, but 
enhances the proliferative responses between a few strain combinations possess- 
ing additional MLC-activating, non-MHC differences. 
The different effects of AFP in the various strain combinations is a reproduc- 
ible phenomenon, thus it can be concluded from this series of experiments that 
the  suppressive  activity  of AFP  on  primary and  secondary proliferative re- 
sponses depends to a great extent on the genetic relationship between respond- 
ing and stimulating strains. 
Effects  of AFP  on  Different  Ly  Subclasses  of Responding  T  Cells.  Data 
obtained  in  the  previous  sections  indicate that  AFP  affects primarily  MLC 
reactions directed against I  region gene products, with little or no activity on 
responses against the SD  region products.  Several recent studies  (40,  49,  50) 
have suggested that the predominant class of T  cells responding against the 
MHC K  and D  region gene products carry the Ly antigen phenotype Ly 1-, 
2+,  3+  (Ly 2,3  cells), whereas the T  cells which proliferate in  response to I 676  SELECTIVE  IMMUNOREGULATORY  EFFECTS  OF  ALPHA-FETOPROTEIN 
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FIG.  4.  Failure of AFP to affect the primary MLC response of B10.G splenic lymphocytes 
towards DBA]2 spleen cells.  B10.G splenic leukocytes and purified splenic T lymphocytes 
were stimulated with X-irradiated DBA/2 spleen cells in the absence (•  •) or presence 
(©  ©)  of  AFP  (150  /~g/ml).  Syngeneic  stimulated  control  cultures  in  the  absence 
(~  an) and presence ([:3  D) of AFP are also shown. [3H]TdR incorporation was deter- 
mined at the time points indicated after a  4 h  pulse with 0.8 ~Ci [SH]TdR per culture. 
region  incompatibilities  are  mainly  of the  phenotype  Ly  1+,  2-,  3-  (Ly  1 
cells).  The following experiments  were performed to determine  whether AFP 
acts principally on Ly 1 cells as might be predicted on the basis of the previous 
results. 
The activated blast cell population isolated from primary mixed cultures of 
B10.S(TR)  responding  against  B10.HTT  (anti-Ia.7  reaction)  has  been  shown 
previously  (46) to consist of T  cells which  are  60-70%  sensitive  to treatment 
with  anti-Ly-2.1  antiserum  plus complement.  Thus,  B10.S(7R) anti-B10.HTT 
blasts  were treated  with  anti-Ly 2.2  antiserum  plus complement to obtain  a 
responding population highly enriched for Ly 1 cells (usually about 90% pure). 
As  shown  in  Table  V,  this  cell  population  is  nearly  twice  as  reactive  in 
secondary  MLC  as the  control  population  treated  with  normal  mouse serum 
plus complement (compared on a  culture to culture basis). AFP suppresses the 
secondary  MLC  activation  of both  the  control  and  the  Ly  2,3  cell-depleted 
populations,  thereby proving that  AFP can effectively inhibit  proliferation  of 
Ly 1 T cells. 
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TABLE  V 
The Effects  of AFP on the In Vitro Restimulation of Ly Subclasses of Splenic T 
Lymphocytes Sensitized against MHC I or MHC SD Region Alloantigens 
Responding T lympho-  Antiserum treat-  Secondary  MLC  Genetic differ-  [3H]TdR  Incorpo-  (cpm  ÷ SD) + 
ration NMS Con- 
cytes*  ment  stimulating cells  ence  trois  AFP* 
B10.S(7R) anti-B10.HTT  NMS +  C'§  B10.S(7R)  None  11,012 -+ 1,366  5,013 ±  2,638 
BI0.HTT  I-C (Is.7)  24,341 ± 868  12,834 _+ 2,051 
anti-Ly 2.2 +  C'  B10.S(7R)  None  11,700 -+ 815  5,444 ±  149 
B10.HTT  I-C (la.7)  40,276 ±  2,081  20,076 -+ 2,131 
B10.G anti-B10.T(6R)  Non~l  B10.G  None  22,586 ±  2,520  15,295 ±  2,136 
B10.T(6R)  MHC D  74,241 -+ 461  68,699 ±  1,127 
* Blast cells isolated on 1 g  velocity sedimentation gradients after peak primary MLC activation. 
* AFP added  at initiation of secondary  MLC  to  •  final concentration of 150  pg/ml. Control cultures  received an  equivalent 
concentration of normal mouse serum (NMS). 
§ Complement-dependent cytotoxicity performed according to the protocol  described  by Shiku et al. (40). 
[I 99% of the total blast population was sensitive to treatment with anti-Ly 2.2 antiserum plus complement. 
TABLE VI 
Effect of AFP on the Secondary Responses  of Different  Ly Subclasses  for the Reaction 
C57BL/6 Anti-DBA/2 
Responding T  Antiserum treatment  Secondary MLC  Genetic difference  [~H]TdR  Incorpora-  (cpm  -+ SD) + 
lymphocytes*  stimulating cells  tion NMS Controls  AFPS 
C57BL/6  anti- 
DBA]2 
NMS +  C'§  C57BL/6  None  898 -+  168  2,494 ±  202 
DBA]2  MHC,  Non.MHC  26,462 ± 2,008  33,288 ± 6,000 
Anti-Ly 2.1  +  C'  C57BL/6  None  878 -+ 423  2,040 -+ 910 
DBA]2  MHC,  Non.MHC  49,193 ± 3,239  41,450 _+ 4,020 
Anti-Ly 2.2 + C'  C57BL/6  None  3,546 ±  618  6,203 ±  1,038 
DBA/2  MHC,  Non-MHC  40,200 ±  122  46,760 ± 3,215 
* Blest cells isolated on 1 g  velocity sedimentation gradients aRer peak primary MLC activation. 
S AFP added  at  initiation of secondary  MLC  to  a  final concentration of 150  pg/ml.  Control cultures received an  equivalent 
concentration of normal mouse serum (NMS). 
§ Complement-dependent cytotoxicity performed according to the protocol  described  by Shiku et el.  (40). 
responding against B10.T(6R), a pure anti-SD reaction, were found to carry Ly 
antigen Ly 2.2 on close to 100% of the responding cells. As shown in both Table 
V and previously in Fig. 2,  AFP does not affect this cell population. 
It  was  earlier  noted  that  primary  MLC  reactivity  against  strain  DBA/2, 
irrespective of whether the responding cells differed genetically at the MHC or 
non-MHC loci (e.g.,  CBA/J,  B10.G, or B10.D2/n responding against  DBA/2 as 
shown in Fig. 4 and Table IV), is either enhanced or unaffected by the presence 
of AFP. This feature is preserved in the secondary MLC responses of activated 
blasts  against  DBA/2,  as  evidenced  by the  reaction  of C57BL/6  anti-DBA/2 
cells presented in Table VI.  If the C57BL/6 anti-DBA/2  cells are treated with 
either  anti-Ly  2.1  or anti-Ly  2.2  antisera  plus  complement,  cell  populations 
result which are considerably more responsive than the control cultures (Table 
VI).  However, like the control cultures, the proliferative responses of the Ly 1 
or Ly 2,3 cell-depleted populations fail to be altered by the presence of AFP. 
Thus,  the  nature  of the  stimulating  alloantigenic  system,  rather  than  the 
actual  Ly  phenotype  class  of the  responding  T-cell  population  may  be  the 
definitive factor determining  susceptibility to the suppressive activity of AFP. 678  SELECTIVE  IMMUNOREGULATORY  EFFECTS  OF  ALPHA-FETOPROTEIN 
Discussion 
The  immune  system  can  be viewed as  functioning  through  a  complicated 
series of intricate  collaborations  which  involve distinct  sets of lymphoid and 
nonlymphoid  cells  as  well  as  soluble factors  interacting  in  a  stimulatory  or 
suppressive manner to create and regulate the immune response.  One soluble 
factor capable of exerting  significant  immunosuppressive effects on T  cells in 
vitro  at  physiological  levels  is  AFP  (7-14).  Since  AFP  is  a  major  alpha- 
globulin  component of fetal and  newborn sera,  and  since the serum levels of 
AFP in pregnant  females is elevated, it must be considered a  possible contrib- 
uting  regulatory  factor  in  vivo  protecting  the  fetus  from  maternal-immune 
attack.  However, after a number of recent investigations which failed to find a 
uniform inhibitory activity for AFP (25-30), the possible importance of AFP as 
an  immunoregulatory  substance  has  been  questioned.  We  believe  that  the 
present  observations not only help to resolve these discrepancies  by pointing 
out that  the  differential  effects which  AFP can  exert on  T-cell  proliferation 
depend on the nature of the stimulating alloantigen(s), but also by demonstrat- 
ing how consistent the previous observations are in reality (9,  10, 23-30). 
The primary aim of this study has been to determine the effects of AFP on 
the recognition and subsequent proliferation of T lymphocytes reacting in MLC 
against  histocompatibility-associated alloantigens.  In the mouse, at least four 
distinct  genetic systems are  known to induce  strong  MLC activation  (41-46): 
the Ia antigens encoded by genes of the MHC I  region, the SD products of the 
MHC K  or D  regions,  the Mls  locus products,  and  the  products  of an  as yet 
undefined non-MHC system (listed in Table I). Analysis of the impact exerted 
by AFP on T-cell proliferative responses towards alloantigens  determined  by 
these four respective genetic systems reveals drastic differences. T-cell reactiv- 
ity  involving  MHC I  region  differences were  markedly  suppressed.  This  in- 
cluded reactions against isolated I  region incompatibilities,  reactions against I 
plus SD region differences, as well as reactions against whole MHC haplotype 
histoincompatibilities.  In contrast,  no detectable inhibition  of T-cell prolifera- 
tion  against  isolated  SD  alloantigens  were observed  (responses  compared  in 
Fig.  2).  Furthermore,  the  partial  suppression  noted  when  measuring  MLC 
reactions against  a  combination of I and SD differences no doubt results from 
this  selective  interference  with  the  proliferation  against  only  the  I  region 
structures. 
The  effects  of  AFP  on  T-cell  responses  against  non-MHC  alloantigenic 
structures  further  reveal  a  selective  suppression.  Nearly  total  inhibition  by 
AFP of stimulation attributable primarily to M/s locus genetic differences was 
noted,  whereas  stimulation  by the  second  non-MHC  locus structures  proved 
refractory  to  suppression.  This  is quite logical  because a  successful response 
against  Mls  locus  structures  requires  a  concomitant  recognition  of I  region 
gene products on the stimulating  cells (46).  No similar I  region requirements 
exist for stimulation  by this  second non-MHC locus structure  (46).  Thus it is 
clear  that  AFP  would  exert  its  suppressive  activity  in  MLCs  via  selective 
interference  with  the I  region  triggering  system(s),  while  failing  to  inhibit 
systems where I  region association is not required. 
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recognition requires concomitant recognition of I  region gene products would 
be suppressed in the presence of AFP. In addition,  the proliferative responses 
against chemically-modified (51) or virus-induced  (52) determinants,  which at 
least  functionally  occur in association  with SD antigens, would remain refrac- 
tive  to suppression. 
It is of  interest  to note that lymphocyte proliferation  was at times enhanced 
by AFP  in particular strain  combinations, most notably in reactions against 
DBA/2  (see Table IV). Because  the AFP  preparations  used in this study 
fulfilled strict criteria for protein purity, the stimulatory effect observed in the 
presence of AFP is most likely due to an intrinsic effect of the added glycoprotein 
per se rather than of a contaminating substance. Immunostimulatory effects of 
AFP in vitro have also been observed in the human system (53,  54). 2 The idea 
that AFP may promote growth of distinct cell typos in vitro is consistent with 
its frequent association in vivo with rapidly dividing cell populations in normal, 
restorative, and malignant conditions. Moreover, albumin,  which shares many 
physicochemical  characteristics  with  AFP  (55),  is  actually  reported  to  be 
essential  for growth of mammalian  lymphocytes in vitro  (56).  We consider it 
entirely  possible,  therefore,  that  AFP possesses both lymphocyte-suppressive 
and  lymphocyte-stimulating  properties.  On  the  basis  of the  data  presented 
within  this  report,  these  two  opposing  regulatory  effects  may  be  directed 
towards functionally distinct lymphocyte targets. 
The possibility that AFP exerts a  suppressive activity on distinct subsets of 
T lymphocytes as defined by Ly antigen phenotypos was also explored in view 
of successful delineation in other systems using this classification of functional 
subsets of T  cells  (40,  49,  50).  From the present  data  (Tables V  and  VI) it is 
clear that  AFP will be a  successful inhibitor  of Ly 1+  T-blast cells reacting 
against  !  region  structures  including  reactions  against  Mls  locus  products, 
while failing to inhibit Ly 2 +  cells being stimulated by SD antigens.  However, 
when using the non-MHC locus alloantigen(s)  as stimulating  agents,  both Ly 
1+  as well as Ly 2+  blast  cells fail to become inhibited  by AFP.  We would 
have to conclude, therefore, that the mere fact that a T-blast cell expresses the 
Ly antigen phenotype Ly 1 +,2-  does not automatically indicate sensitivity to 
suppression  by AFP.  Rather,  the  more  decisive factor  determining  whether 
AFP  will  function  as  an  efficient  inhibitor  or  not  lies  at  the  level  of the 
triggering structures.  It should be realized,  in any case, that AFP may have a 
dual  requirement,  first  for  a  particular  subset  of T  cells,  and  second  for  a 
distinct stimulating unit. 
Although  the precise mechanism  of AFP suppression  remains  obscure, the 
present data add further weight to the earlier findings that AFP does exert a 
selective inhibitory capacity on T-dependent immune responses (7-10, 23). 2 This 
inhibition  depends,  at  least  in  part,  on  the  ability  of AFP to  induce  highly 
efficient suppressor  T  cells  (24).  The  potential  importance  of the  production 
of suppressor cells for inhibition of the proliferative MLC responses noted here 
still must be explored. Furthermore, the present data leave open the question of 
whether AFP exerts a  direct anti-proliferative effect on specific MLC reactive 
T  cells or suppresses through  interference by binding  to relevant  recognition 
structures  on target  cell  surfaces.  Nevertheless,  AFP appears  to regulate  T- 680  SELECTIVE  IMMUNOREGULATORY  EFFECTS  OF  ALPHA-FETOPROTEIN 
cell-dependent-immune responses in vitro in a highly selective manner which 
we suggest is indicative of a  potentially important immunoregulatory role in 
vivo.  Further discussion of this topic  is presented in the second paper of this 
series  3 in  which AFP  is  shown to  inhibit  development of cytotoxic T  cells 
against SD region antigens despite the fact that the proliferative responses are 
quantitatively unaltered. 
In conclusion, these data indicate that the normal fetal serum protein AFP is 
endowed with  selective ability to  abrogate  in  vitro  T-cell  proliferation to I 
region determinants. Although not resolving the question as  to  the in vivo 
relevance of AFP as an  immunosuppressive agent, these results provide an 
explanation why earlier reports  which failed to  investigate the  underlying 
genetic requirements yielded contradictory results as to the in vitro immuno- 
suppressive potential of AFP. Further analysis of how AFP exerts this selective 
activity with respect to anti-/region reactions may provide a new approach in 
the search for the actual functions of I  region gene products. 
Summary 
Alpha-fetoprotein  (AFP),  a  major  alpha-globulin  component of fetal  and 
newborn sera, has earlier been shown to exert significant immunosuppressive 
activity in vitro on T-dependent-immune  responses. In the present investigation 
we have examined the effects of AFP on the recognition and proliferation of T 
lymphocytes responding in mixed leukocyte culture against histocompatibility- 
associated alloantigens. Fetal-derived AFP could be shown to exert differential 
effects on both primary and secondary responses ranging from strong inhibition 
to occasional enhancement, depending on the stimulating antigens. Prolifera- 
tive responses against major histocompatibility complex (MHC) I region deter- 
minants, mediated predominantly by Ly 1  +  cells, were markedly suppressed. 
Suppression was also  observed in responses against Mls  locus products,  an 
antigenic  system  whose  recognition  requires  concomitant  recognition  of I 
region gene products on the stimulating cells.  In contrast, responses against 
MHC K  or D region determinants, mediated predominantly by Ly 2+  cells, 
were  generally  unaffected by  AFP.  Similarly,  non-MHC  loci  alloantigens 
distinct from Mls  locus products also induced T-cell proliferation which was 
refractive to  suppression  by AFP.  Because neither Ly  1+  nor  Ly 2+  cells 
responding in this latter situation could be inhibited by AFP, we conclude that 
the  mere fact  that  a  T  cell  expresses  a  particular  Ly phenotype does not 
predetermine sensitivity to AFP-induced suppression. In any case, AFP exerts 
a highly selective suppressive activity on I region-associated immune responses. 
These data may help to resolve the present controversy over the possibility 
that AFP has an in vivo relevance as an immunosuppressive agent by pointing 
out the importance of selecting proper genetic situations for study. 
The authors wish to thank Ms. Gunilla Andersson for  her excellent  technical assistance  during 
this  study. 
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